1887
Preview this article:
Zoom in
Zoomout

A CTX-M extended-spectrum -lactamase in and , Page 1 of 1

| /docserver/preview/fulltext/jmm/55/11/1607-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46704-0
2006-11-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/55/11/1607.html?itemId=/content/journal/jmm/10.1099/jmm.0.46704-0&mimeType=html&fmt=ahah

References

  1. al Naiemi, N. A., Duim, B., Savelkoul, P. H. M., Spanjaard, L., de Jonge, E., Bart, A., Vandenbroucke-Grauls, C. M. & de Jong, M. D. ( 2005; ). Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43, 4862–4864.[CrossRef]
    [Google Scholar]
  2. Bonnet, R. ( 2004; ). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1–14.[CrossRef]
    [Google Scholar]
  3. Bonnet, R., Dutour, C., Sampaio, J. L. M., Chanal, C., Sirot, D., Labia, R., De Champs, C. & Sirot, J. ( 2001; ). Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 45, 2269–2275.[CrossRef]
    [Google Scholar]
  4. Bradford, P. A. ( 2001; ). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933–951.[CrossRef]
    [Google Scholar]
  5. Eckert, C., Gautier, V. & Arlet, G. ( 2006; ). DNA sequence analysis of the genetic environment of various bla CTX-M genes. J Antimicrob Chemother 57, 14–23.
    [Google Scholar]
  6. Livermore, D. M. ( 1991; ). β-Lactamases of Pseudomonas aeruginosa. Antibiot Chemother 44, 215–220.
    [Google Scholar]
  7. Matsumoto, Y., Ikeda, F., Kamimura, T., Yokota, Y. & Mine, Y. ( 1988; ). Novel plasmid-mediated β-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins. Antimicrob Agents Chemother 32, 1243–1246.[CrossRef]
    [Google Scholar]
  8. Nagano, N., Nagano, Y., Cordevant, C., Shibata, N. & Arakawa, Y. ( 2004; ). Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol 42, 3978–3984.[CrossRef]
    [Google Scholar]
  9. NCCLS ( 2005; ). Performance standards for antimicrobial susceptibility testing; 15th informational supplement (M100-S15). Wayne, PA: National Committee for Clinical Laboratory Standards.
  10. Paterson, D. L. & Bonomo, R. A. ( 2005; ). Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18, 657–686.[CrossRef]
    [Google Scholar]
  11. Pitout, J. D. D., Nordmann, P., Laupland, K. B. & Poirel, L. ( 2005; ). Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 56, 52–59.[CrossRef]
    [Google Scholar]
  12. Ramadan, M. A., Tawfik, A. F. & Shibl, A. M. ( 1995; ). Effect of β-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to β-lactam antibiotics. Chemotherapy 41, 193–199.[CrossRef]
    [Google Scholar]
  13. Relman, D. A., Schmidt, T. M., MacDermott, R. P. & Falkow, S. ( 1992; ). Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 327, 293–301.[CrossRef]
    [Google Scholar]
  14. Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A., Perroux, R. & Cluzel, R. ( 1987; ). Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 20, 323–334.[CrossRef]
    [Google Scholar]
  15. Walsh, T. R., MacGowan, A. P. & Bennett, P. M. ( 1997; ). Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 41, 1460–1464.
    [Google Scholar]
  16. Weldhagen, G. F., Poirel, L. & Nordmann, P. ( 2003; ). Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 47, 2385–2392.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46704-0
Loading
/content/journal/jmm/10.1099/jmm.0.46704-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error